In this study, we want to compare a new drug for multiple sclerosis (MS) with a drug that is already being used. We want to see how the new drug works and if it might be a better option for treating MS.
Thank you for your interest, but this study is not currently enrolling.
United States (Nationwide)
Irena Dujmovic Basuroski
Neurology
Clinical or Medical
Interventional
Brain, Head, Nervous System
23-2366
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
